rs1057519784
|
|
Adenocarcinoma of lung (disorder)
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Ceritinib in ALK-rearranged non-small-cell lung cancer.
|
24670165 |
2014 |
rs1057519782
|
|
Adenocarcinoma of lung (disorder)
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Ceritinib in ALK-rearranged non-small-cell lung cancer.
|
24670165 |
2014 |
rs1057519781
|
|
Adenocarcinoma of lung (disorder)
|
G |
0.700 |
GeneticVariation
|
CLINVAR |
Ceritinib in ALK-rearranged non-small-cell lung cancer.
|
24670165 |
2014 |
rs779318085
|
|
Adenocarcinoma of lung (disorder)
|
|
0.010 |
GeneticVariation
|
BEFREE |
Detection of PIK3CA mutations, including a novel mutation of V344G in exon 4, in metastatic lung adenocarcinomas: A retrospective study of 115 FNA cases.
|
27007084 |
2016 |
rs1057519784
|
|
Adenocarcinoma of lung (disorder)
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Furthermore, HSP90 inhibition, as well as the second-generation ALK inhibitor TAE684, demonstrated activity in newly developed lung adenocarcinoma models driven by crizotinib-insensitive EML4-ALK L1196M or F1174L.
|
24327273 |
2014 |
rs863225281
|
|
Adenocarcinoma of lung (disorder)
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
Furthermore, HSP90 inhibition, as well as the second-generation ALK inhibitor TAE684, demonstrated activity in newly developed lung adenocarcinoma models driven by crizotinib-insensitive EML4-ALK L1196M or F1174L.
|
24327273 |
2014 |
rs863225281
|
|
Adenocarcinoma of lung (disorder)
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Furthermore, HSP90 inhibition, as well as the second-generation ALK inhibitor TAE684, demonstrated activity in newly developed lung adenocarcinoma models driven by crizotinib-insensitive EML4-ALK L1196M or F1174L.
|
24327273 |
2014 |
rs863225281
|
|
Adenocarcinoma of lung (disorder)
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers.
|
22277784 |
2012 |
rs863225281
|
|
Adenocarcinoma of lung (disorder)
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers.
|
22277784 |
2012 |
rs1057519785
|
|
Adenocarcinoma of lung (disorder)
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers.
|
22277784 |
2012 |
rs1057519784
|
|
Adenocarcinoma of lung (disorder)
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers.
|
22277784 |
2012 |
rs1057519783
|
|
Adenocarcinoma of lung (disorder)
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers.
|
22277784 |
2012 |
rs1057519782
|
|
Adenocarcinoma of lung (disorder)
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers.
|
22277784 |
2012 |
rs1057519781
|
|
Adenocarcinoma of lung (disorder)
|
G |
0.700 |
GeneticVariation
|
CLINVAR |
Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers.
|
22277784 |
2012 |